Veracyte (VCYT) Net Income towards Common Stockholders (QoQ) (2012 - 2026)
Veracyte (VCYT) Net Income towards Common Stockholders (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn |
| 10 | Veracyte | 3.84 Bn | 3.58 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.31% |
| Dec 31, 2025 | 115.02% |
| Sep 30, 2025 | 2,114.42% |
| Jun 30, 2025 | -113.48% |
| Mar 31, 2025 | 37.83% |
| Dec 31, 2024 | -66.26% |
| Sep 30, 2024 | 164.30% |
| Jun 30, 2024 | 407.62% |
| Mar 31, 2024 | 93.41% |
| Dec 31, 2023 | 4.37% |
| Sep 30, 2023 | -251.96% |
| Jun 30, 2023 | -3.84% |
| Mar 31, 2023 | -111.97% |
| Dec 31, 2022 | 56.24% |
| Sep 30, 2022 | 8.63% |
| Jun 30, 2022 | 33.98% |
| Mar 31, 2022 | -37.96% |
| Dec 31, 2021 | 25.81% |
| Sep 30, 2021 | -56.33% |
| Jun 30, 2021 | 78.41% |